Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial
暂无分享,去创建一个
A. Bergen | A. Schatzkin | R. Modali | T. Lehman | A. Cross | Binbing Yu | A. Laiyemo | G. Murphy | Zhuoqiao Wang | E. Lanza | Aravind Kalidindi | Leah S. Sansbury | Paul S Albert | Adeyinka O. Laiyemo | Leah S. Sansbury
[1] H. Ko,et al. Specific personality traits and dopamine, serotonin genes in anxiety–depressive alcoholism among Han Chinese in Taiwan , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[2] E. Molinari,et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity , 2007, Eating and weight disorders : EWD.
[3] Nilanjan Chatterjee,et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2006, Pharmacogenetics and genomics.
[4] N. Chatterjee,et al. Inflammatory Cytokine Gene Polymorphisms, Nonsteroidal Anti-Inflammatory Drug Use, and Risk of Adenoma Polyp Recurrence in the Polyp Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.
[5] S. Carobbio,et al. Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion* , 2005, Journal of Biological Chemistry.
[6] Federica Gemignani,et al. Polymorphisms of the Dopamine Receptor Gene DRD2 and Colorectal Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.
[7] N. Saitou,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.
[8] Jean Logan,et al. Brain dopamine and obesity , 2001, The Lancet.
[9] S. Basu,et al. Decreased Dopamine Receptor Expression and Its Second-Messenger cAMP in Malignant Human Colon Tissue , 1999, Digestive Diseases and Sciences.
[10] D. Collier,et al. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia , 1998, Schizophrenia Research.
[11] J O Rinne,et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.
[12] É. Mezey,et al. Substantial production of dopamine in the human gastrointestinal tract. , 1997, The Journal of clinical endocrinology and metabolism.
[13] T. Arinami,et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.
[14] D. Comings,et al. The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.
[15] J. Weissfeld,et al. The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] A. Schatzkin,et al. The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] R. Klein,et al. A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. , 1993, The Journal of nutrition.
[18] G. Mason,et al. Dopamine receptors in human gastrointestinal mucosa. , 1987, Life sciences.
[19] G Block,et al. A data-based approach to diet questionnaire design and testing. , 1986, American journal of epidemiology.
[20] E. Ponce,et al. World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. United Kingdom: WCRF/AICR, 2001 , 2009 .
[21] E. Noble,et al. Association of Seven Polymorphisms of the D2 Dopamine Receptor Gene with Brain Receptor-Binding Characteristics , 2004, Neurochemical Research.
[22] North American Association for the Study of Obesity , 1991, International journal of obesity.